title: [Continuous ambulatory intravenous morphine infusion for pain therapy in advanced ovarian cancer].
abstract: We report on a female outpatient with cancer of the ovary, who received continuous intravenous morphine infusion for terminal pain control. The patient was treated over a period of 48 days with a morphine dosage ranging from 10 to 60 mg/h, which kept her free of pain. With treatment, she was alert, communicative with her relatives and moved freely. At a later stage, we complemented the treatment with Diazepam and Haloperidol. No side-effects were observed over the whole period of morphine infusion.
authors.affiliation: Abteilung IV, Zentrum Anästhesiologie, Medizinischen Hochschule Hannover.
authors.forename: J
authors.initials: J
authors.lastname: Sorge
authors.forename: I
authors.initials: I
authors.lastname: Schönborn
authors.forename: H H
authors.initials: HH
authors.lastname: Günter
authors.forename: B
authors.initials: B
authors.lastname: Steffmann
authors.forename: J
authors.initials: J
authors.lastname: Hilfrich
authors.forename: H
authors.initials: H
authors.lastname: Kühnle
mesh_terms: D003975:Diazepam / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D007260:Infusion Pumps; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000503:physiopathology*; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*
chemical_list: D009020:Morphine; D006220:Haloperidol; D003975:Diazepam